Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ELVN | BCRX | ORKA | ||
| Company | Enliven Therapeutics Inc | Biocryst Pharma Inc | Oruka Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 38.29 | 9.28 | 44.53 | ||
| High | 39.22 | 9.52 | 45.78 | ||
| Low | 35.60 | 9.17 | 43.50 | ||
| Latest | 36.59 | 9.45 | 45.52 | ||
| Change | -2.24 | +0.12 | +1.04 | ||
| % Change | -5.77% | +1.29% | +2.34% | ||
| Volume | 2,004,290 | 2,986,212 | 827,148 | ||
| 20-Day Average Volume | 1,550,474 | 6,928,806 | 730,077 | ||
| Previous Close | 38.83 | 9.33 | 44.48 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 30.92 | 9.05 | 38.50 | ||
| 20-Day Raw Stochastic | 71.05% | 59.91% | 89.14% | ||
| 20-Day Relative Strength | 65.70 | 62.75 | 66.13 | ||
| Weighted Alpha | +38.45 | +39.57 | +396.83 | ||
| Today's Opinion | 100% Buy | 72% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 72% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | Hold | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +18.76% since 03/23/26 | -3.57% since 03/23/26 | +9.53% since 03/23/26 | ||
| Low | 29.37 on 03/24/26 | 8.89 on 03/26/26 | 39.05 on 03/24/26 | ||
| High | 40.62 on 03/26/26 | 10.13 on 03/24/26 | 47.25 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | +23.24% since 02/27/26 | +8.00% since 02/27/26 | +32.29% since 02/27/26 | ||
| Low | 26.70 on 03/18/26 | 8.15 on 03/13/26 | 31.32 on 03/12/26 | ||
| High | 40.62 on 03/26/26 | 10.32 on 03/20/26 | 47.25 on 03/26/26 | ||
| 3-Month | |||||
| %Chg | +124.48% since 12/26/25 | +23.85% since 12/26/25 | +43.60% since 12/26/25 | ||
| Low | 14.78 on 01/06/26 | 6.23 on 02/05/26 | 25.23 on 01/05/26 | ||
| High | 40.62 on 03/26/26 | 10.32 on 03/20/26 | 47.25 on 03/26/26 | ||
| 6-Month | |||||
| %Chg | +82.86% since 09/26/25 | +23.85% since 09/26/25 | +199.47% since 09/26/25 | ||
| Low | 14.78 on 01/06/26 | 6.00 on 10/14/25 | 15.77 on 09/29/25 | ||
| High | 40.62 on 03/26/26 | 10.32 on 03/20/26 | 47.25 on 03/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,322,034 | 2,339,973 | 2,203,672 | ||
| Shares Outstanding, K | 59,800 | 250,801 | 49,543 | ||
| Annual Sales | 0 | 874,840,000 | 0 | ||
| Annual Net Income | -103,690,000 | 263,860,000 | -105,430,000 | ||
| Last Quarter Sales | 0 | 406,560,000 | 0 | ||
| Last Quarter Net Income | -29,670,000 | 245,850,000 | -29,580,000 | ||
| 60-Month Beta | 0.33 | 0.74 | -0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.48 on 03/03/26 | 1.12 on 02/26/26 | -0.45 on 03/12/26 | ||
| Latest Earnings Date | 05/13/26 | 05/04/26 | 05/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 7.19 | 0.00 | ||